Phase 2 Prematurity Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
Retinopathy of Prematurity
University of Zurich276 enrolled3 locationsNCT03083431
Recruiting
Phase 2
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Iron-Deficiency AnemiaIron-deficiencyPrematurity+1 more
University of Washington120 enrolled1 locationNCT05340465
Recruiting
Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Intraventricular hemorrhageChronic lung disease of prematurityBronchopulmonary Dysplasia+1 more
OHB Neonatology Ltd.338 enrolled66 locationsNCT03253263
Recruiting
Phase 2Phase 3
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
Respiratory DiseaseVentilator Lung; NewbornPrematurity
Ministry of Health, Saudi Arabia134 enrolled2 locationsNCT06026163
Recruiting
Phase 2Phase 3
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
Retinopathy of Prematurity
Asociación para Evitar la Ceguera en México1 locationNCT00346814
Recruiting
Phase 2
Doxapram for Apnoea of Prematurity (DoxAPrem) Dosage Study
Apnoea of prematurity
University of Auckland32 enrolled1 locationACTRN12621001163897
Recruiting
Phase 2
Randomized controlled trial (RCT) comparing between High versus Standard dose caffeine citrate for apnoea in prematurity
Apnoea of prematurity
Hospital Universiti Sains Malaysia78 enrolled1 locationACTRN12619001708145